1. Second Sight enters South Korea market
Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation of two patients with its Argus II Retinal Prosthesis System in Seoul. The implants were made possible by the country’s distribution partner Kisantech Co.
2. K2M touts Japan distribution deal with Mitsubishi
K2M signed a new, long-term exclusive agreement with Mitsubishi to distribute its spinal technologies in Japan, according to a July 10 press release. The agreement names Japan Medicalnext as the exclusive distributor of K2M’s spine products in Japan, and the terms of the agreement extend the partnership for seven years.
3. Hill-Rom launches safety surgical instruments line
Hill-Rom announced in a July 17 press release that it is launching a new line of safety surgical instruments that include the Bard Parker SafeSwitch disposable scalpel handle and scalpel handle cover and the new Bard Parker blade remover. The products are designed to help surgeons and their teams prevent injuries that can happen at all times during a procedure. The Bard Parker SafeSwitch disposable scalpel handles give surgeons the ability to safely retract, pass and disarm blades in one step and with one hand. The blade remover allows surgeons to remove up to five contaminated blades per remover without having to touch the blade.
4. ApiFix inks Spanish distribution deal
ApiFix announced that it has signed an exclusive distribution deal in Spain with Acuna-Fombona, according to a July 18 press release. ApiFix develops a minimally-invasive, non-fusion spinal implant system that results in short procedure and recovery times while maintaining spine flexibility.
5. Reha Technology gets 510(k) clearance for electrostim with rehab robot
Reha Technology announced in a July 18 press release that it is going to begin to offer the newly FDA-approved integrated Functional Electronic Stimulation (FES) for their G-EO System Evolution robotic gait trainer. FES with the G-EO System has previously shown success in Europe and Asia and the company plans to broaden the adoption of the FES technology in the U.S. market to give therapists other treatment options for patients.
6. Alpha Tau Medical claims second funding round
Alpha Tau Medical announced that it has raised 20% more capital than it originally planned for its Alpha DaRT cancer treatment, according to a July 18 press release. The company plans to use the funding to further develop the treatment as a highly potent and conformal treatment for 11 different types of tumors. In its first clinical study, the Alpha DaRT showed that it could effectively destroy solid tumors with no adverse effects. The treatment was performed under local anesthesia and did not need special shielding or capital equipment. The treatment took 60 minutes.
7. Sanuwave signs Indonesia distribution deal
Sanuwave Health announced in a July 20 press release that Alat Medika Indonesia will be its distributor for its dermaPACE and the liaison for clinical trials participation for Sanuwave’s wound care product in Indonesia. The company expects revenue to rise to over $M over the next three years because of the distribution deal.